Ramsay Health Care Past Earnings Performance
Past criteria checks 0/6
Ramsay Health Care's earnings have been declining at an average annual rate of -13.5%, while the Healthcare industry saw earnings growing at 1.5% annually. Revenues have been growing at an average rate of 6.8% per year. Ramsay Health Care's return on equity is 4.7%, and it has net margins of 1.4%.
Key information
-13.5%
Earnings growth rate
-16.3%
EPS growth rate
Healthcare Industry Growth | 2.4% |
Revenue growth rate | 6.8% |
Return on equity | 4.7% |
Net Margin | 1.4% |
Next Earnings Update | 30 Aug 2024 |
Recent past performance updates
Recent updates
Ramsay Health Care (ASX:RHC) Seems To Use Debt Quite Sensibly
Mar 29Ramsay Health Care (ASX:RHC) Has Re-Affirmed Its Dividend Of AU$0.48
Feb 27Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 68% Above Its Share Price
Feb 15We Think Ramsay Health Care (ASX:RHC) Is Taking Some Risk With Its Debt
Sep 16Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital
Aug 22Is There An Opportunity With Ramsay Health Care Limited's (ASX:RHC) 27% Undervaluation?
Jun 22Does Ramsay Health Care (ASX:RHC) Have A Healthy Balance Sheet?
Jun 07There Are Reasons To Feel Uneasy About Ramsay Health Care's (ASX:RHC) Returns On Capital
May 09What Is The Ownership Structure Like For Ramsay Health Care Limited (ASX:RHC)?
Mar 16Income Investors Should Know That Ramsay Health Care Limited (ASX:RHC) Goes Ex-Dividend Soon
Mar 03Ramsay Health Care Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 26Are Insiders Buying Ramsay Health Care Limited (ASX:RHC) Stock?
Feb 15Revenue & Expenses BreakdownBeta
How Ramsay Health Care makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 15,945 | 221 | 0 | 0 |
30 Sep 23 | 15,561 | 274 | 0 | 0 |
30 Jun 23 | 14,964 | 265 | 0 | 0 |
31 Mar 23 | 14,418 | 299 | 0 | 0 |
31 Dec 22 | 13,943 | 272 | 0 | 0 |
30 Sep 22 | 13,528 | 264 | 0 | 0 |
30 Jun 22 | 13,312 | 250 | 0 | 0 |
31 Mar 22 | 13,404 | 311 | 0 | 0 |
31 Dec 21 | 13,008 | 373 | 0 | 0 |
30 Sep 21 | 12,929 | 387 | 0 | 0 |
30 Jun 21 | 12,864 | 440 | 0 | 0 |
31 Mar 21 | 12,511 | 341 | 0 | 0 |
31 Dec 20 | 12,157 | 242 | 0 | 0 |
30 Sep 20 | 12,159 | 257 | 0 | 0 |
30 Jun 20 | 12,160 | 273 | 0 | 0 |
31 Mar 20 | 12,438 | 397 | 0 | 0 |
31 Dec 19 | 12,717 | 521 | 0 | 0 |
30 Sep 19 | 12,135 | 527 | 0 | 0 |
30 Jun 19 | 11,553 | 533 | 0 | 0 |
31 Mar 19 | 10,726 | 466 | 0 | 0 |
31 Dec 18 | 9,899 | 399 | 0 | 0 |
30 Sep 18 | 9,538 | 388 | 0 | 0 |
30 Jun 18 | 9,176 | 376 | 0 | 0 |
31 Mar 18 | 9,003 | 422 | 0 | 0 |
31 Dec 17 | 8,831 | 467 | 0 | 0 |
30 Sep 17 | 8,767 | 472 | 0 | 0 |
30 Jun 17 | 8,703 | 476 | 0 | 0 |
31 Mar 17 | 8,766 | 472 | 0 | 0 |
31 Dec 16 | 8,829 | 468 | 0 | 0 |
30 Sep 16 | 8,758 | 453 | 0 | 0 |
30 Jun 16 | 8,686 | 437 | 0 | 0 |
31 Mar 16 | 8,438 | 421 | 0 | 0 |
31 Dec 15 | 8,190 | 406 | 0 | 0 |
30 Sep 15 | 7,773 | 389 | 0 | 0 |
30 Jun 15 | 7,357 | 372 | 0 | 0 |
31 Mar 15 | 6,626 | 348 | 0 | 0 |
31 Dec 14 | 5,895 | 324 | 0 | 0 |
30 Sep 14 | 5,405 | 307 | 0 | 0 |
30 Jun 14 | 4,915 | 290 | 0 | 0 |
31 Mar 14 | 4,690 | 281 | -65 | 0 |
31 Dec 13 | 4,466 | 271 | -131 | 0 |
30 Sep 13 | 4,322 | 261 | -65 | 0 |
30 Jun 13 | 4,177 | 251 | 0 | 0 |
Quality Earnings: RHC has a large one-off gain of A$126.3M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: RHC's current net profit margins (1.4%) are lower than last year (2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RHC's earnings have declined by 13.5% per year over the past 5 years.
Accelerating Growth: RHC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: RHC had negative earnings growth (-19.1%) over the past year, making it difficult to compare to the Healthcare industry average (-19.1%).
Return on Equity
High ROE: RHC's Return on Equity (4.7%) is considered low.